lobbying_activities: 2112967

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2112967	3db1af50-046d-455b-9105-d95df1410986	Q1	APOTEX CORP.	310973	APOTEX CORP.	2018	first_quarter	CPT	Federal policy relating to inter partes review challenges of pharmaceutical and biotechnology patents.	HOUSE OF REPRESENTATIVES,SENATE		160000	0	0	2018-04-19T09:24:22.117000-04:00